Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Long-term immunity against Coronavirus is a myth

CAN GENETIC MUTATION LEAD TO MATERNAL DEATH AFTER CHILD BIRTH?

Climate change and Antibiotic resistance development

Long-term immunity against Coronavirus is a myth
  • BiotechToday
  • World

Long-term immunity against Coronavirus is a myth

bioxone October 5, 2020October 5, 2020

Devyani Goswami, Amity University Kolkata

It is about a year now that the SARS-CoV-2 has disturbed and changed the daily lifestyle of people all over the world. A vaccine against this virus is what we are hoping for, but that too comes with a drawback that it won’t be able to provide a long-term immunity as it is expected from it. It is not the first time that we are experiencing a coronavirus outbreak; 2002, 2004, 2012, 2015, 2018 had reported outbreaks of coronavirus.

Coronavirus disease is a seasonal disease, occurring mainly in winter months and affecting the temperate regions (severity might be less in the tropical regions). Researchers have majorly focused on the strains of human infecting coronaviruses which are known for producing common cold-like symptoms, HCoV-OC43, HCoV-HKU1, HCoV-229E and HCoV-NL63 for the last 35 years and concluded that a long-term immunity is unlikely to achieve. 

Researchers analyzed 513 samples collected since the 1980s from 10 healthy males in Amsterdam and noticed several spikes of proteins attached to the coronavirus. These spikes were interpreted to be as reinfection and studying all the strains of human infecting coronavirus, found 3-17 infections per patient. Reinfection cases showed up as early as six months to one year after the first infection. Samples were collected in an interval of every six months, as some coronavirus infections are asymptomatic.  

It is not yet confirmed whether SARS-CoV-2 follows the same features, although there are cases of reinfection. Researchers believe that like other strains, SARS-CoV-2 might be more prevalent in the winter. As in the study, the months of July, August, September showed lower rate of infection than in the months of winter in Amsterdam. Although more studies are required on this topic.

It is already the beginning of the autumn, what the future holds for us is totally unknown. Whether the vaccine would be able to provide a complete immunity remains in dark. Following the precautions is what we can do for now and lower the percentage of transmission. 

Also read: Organic Pesticides- a boon or a bane?

REFERENCE: 35 Years of research into coronavirus infection show long-term immunity is unlikely – Carly Cassella

https://www.sciencealert.com/35-year-study-of-coronavirus-reinfections-suggests-human-immunity-is-short-lived

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibody antigens CORONAVIRUS HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 immune span immunity long term SARS-CoV-2 spike protein

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Climate change and Antibiotic resistance development

bioxone October 5, 2020

Soumya Sarathi Ganguly, Indian Institute of Technology, Kharagpur Bacterial infections leading to diseases or in many of the times increasing the severity of another disease are one of the most common issues faced by human beings. Increased resistance against mostly used antibiotics (drugs) is presently the biggest concern for healthcare professionals and the general public. […]

Antibiotic resistance

Related Post

  • BiotechToday
  • World

UV-linked mutations can shape genome sequence changes!

bioxone January 20, 2021January 20, 2021

Ayooshi Mitra, Amity University Kolkata A genomic study of skin cells shows that there is a wide range of age-independent mutations in the normal number of somatic mutations that arise from exposure to UV light. The human skin is constantly subjected to damage of DNA due to the environment, which leads to the accumulation of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Is there a cure for Alzheimer’s Disease?

bioxone May 1, 2021May 1, 2021

Camelia Bhattacharyya, Amity University Kolkata Memories, something we all look back to; it holds stories of joy, happiness, pain and all the firsts in life. Thus, memories are special, and they are the most prized possession. But what if these memories are lost along with the loss of proper functioning of the brain and the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

LDLR and its role in Hepatitis B infection

bioxone July 25, 2021July 24, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics HBV – Hepatitis B virus infects more than 200 million people around the world. The virus results in liver diseases such as hepatitis, cirrhosis, fibrosis, and hepatocellular carcinoma (HCC). Prophylactic HBV vaccine reduces the number of infections but fails to offer a therapeutic benefit to chronically […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy